AI-Powered home health RCM, coding, and OASIS QR platform

AI-native biotech harnessing self-supervised learning and spatial biology to discover better precision immunotherapies

Leveraging advanced rocket engine technology to convert waste into clean energy and fresh water, while permanently removing CO2 from the atmosphere. Founded by former SpaceX engineers.

Research platform which is embedded across a global network of healthcare institutions, researchers can rapidly access and prospectively engage with patients to generate insights derived from the decentralised collection of electronic health records, clinical outcomes, patient-reported data and biosamples

Leveraging AI, data-science, and software to build the future healthcare workforce

Early stage investor in founders solving the biggest challenges facing our worldBoard Member: MatchwellBoard Observer: uMed, Hinge HealthInvestor: Arbor - Carbon sequestration / energy startup founded by former SpaceX engineersNoetik - AI-native biotech harnessing self-supervised learning to discover better precision immunotherapies

30Ventures is an early-stage healthcare and biotechnology venture capital firm focused on high-potential, capital-efficient companies. 30Ventures partners with founders at the Series A/B stage located in undercapitalized geographies, developing innovations that can impact human healthcare. Main focus areas: Digital Health (Digital Therapeutics, AI/ML, SaaS), MedTech and Precision Medicine

- Led consulting project with a Fortune 500 insurance company on their venture capital and M&A strategy- Led consulting project with technology transfer office managing a +$3B endowment on vetting viable technologies to fund and spin out into companies- Advised 30+ startups associated with the University- Assisted teaching Venture Creation to 20+ aspiring undergraduate entrepreneurs- Completed a thesis on first-time VC fund construction in the Midwest

Lewis & Clark Ventures is a $125M VC firm based in St. Louis, MO that invests in high potential Series A and B stage companies in sectors such as digital health, software, FinTech, business enterprise solutions, life sciences, and agriculture.

gener8tor invests its community, capital, expertise, mentorship and network in capable, early-stage entrepreneurs with innovative business models. gener8tor works with the startups in its portfolio to create successful, scalable companies. gener8tor invests in technology-enabled businesses, including software, IT, web, SaaS, e-commerce and hardware. - Consulted companies within the start-up accelerator to measure KPI's and determine realistic growth projections for potential investors, resulting in 5 of the companies raising over $1 million in seed round financing each- Improved the sales and operation process of 5 of the companies, decreasing customer acquisition cost and increasing monthly reoccurring revenue (MRR) by 20% month over month- Recruited, evaluated and screened 700+ startups for future gener8tor programs by determining which companies are venture capital ready and will have a high return on investment- Facilitated investor relations with 100+ VC partners and angel investors- Initiated financial practices within the startups; creating P&L, balance sheet and cash flow projections

Gellman Group- Biochemistry undergraduate thesis examining the characteristics and synthesis of an antimicrobial peptide targeting Staph infections- Performed experiments synthesizing and purifying complex peptides- Assisted a postdoctoral researcher in antimicrobial peptide and organic chemistry experiments to aid in publishing his research- Analyzed data from experiments using a multitude of statistical analysis programs

- Designed and ran emotional response psychology experiments with graduate students to study emotional recognition in children- Statistically analyzed experimental data using Excel, SPSS, JavaScript and R